Diversity of congenital disorders of glycosylation
- 作者James Leonard; Stephanie Grünewald; Peter Clayton
- 卷第357卷
- 期第9266期
- 印刷ISSN0140-6736
- 电子ISSN1474-547X
- 文件大小53.69KB
- 发表时间2001
- DOI10.1016/s0140-6736(00)04618-3
Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes MellitusFonseca, Vivian; Rosenstock, Julio; Patwardhan, Rita; Salzman, Alan · JAMA · 2000
Retrospective Analysis of Rosiglitazone and Macular Oedema in Patients with Type 2 Diabetes MellitusDr Patrizio Tatti, Franco Arrigoni, Adriano Longobardi, Flavia Costanza, Patrizia Di Blasi, Domenico Merante · 2008
The effects of metformin and rosiglitazone on heart rate variability in type 2 diabetes mellitusCelal Kilit; Serap Demir; Turkan Pasali Kilit; Mehmet Melek · 2007
The effects of metformin and rosiglitazone on heart rate turbulence in type 2 diabetes mellitusCelal Kilit; Serap Demir; Turkan Pasali Kilit; Mehmet Melek · 2007
Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitusMarina Shargorodsky; Gulio Wainstein; Eyal Gavish; Ziporah Leibovitz; Dov Matas; Reuven Zimlichman · 2003
Implications of Rosiglitazone and Pioglitazone on Cardiovascular Risk in Patients with Type 2 Diabetes MellitusDr. Brian K. Irons; Dr. Ronald Shane Greene; Dr. Timothy A. Mazzolini; Dr. Krystal L. Edwards; Dr. Rebecca B. Sleeper · 2006
Rosiglitazone [Avandia] does not increase the risk of cardiovascular mortality and morbidity in patients with type 2 diabetes mellitusReactions Weekly · 2008